Emerging Selective Interleukin-23 (IL-23) Inhibitors

Safety, Efficacy and Putative Mechanisms of Action of Emerging Selective Interleukin-23 (IL-23) Inhibitors in the Treatment of Inflammatory Bowel Disease: Focus on Risankizumab & Mirikizumab What is inflammatory bowel disease and what are the symptoms what are the current medications and their limitations and why there is new treatment being tested. https://www.hindawi.com/journals/mi/2015/493012/